Weekly news - 29th September 2017


Weekly subscribe button

Stoptober resources

From our free app and daily emails, to face-to-face expert support and much more – we've got loads of support to help you quit, so choose the combination that's right for you | NHS, UK

 

In date order, Monday to Friday

Public Health England marketing strategy: 2017 to 2020

This strategy sets out Public Health England's 3-year strategic framework | PHE, UK

Government accused of cutting vital drug and alcohol services as £43m slashed from addiction budgets

The Government has been accused of presiding over “staggering cuts” to vital drug and alcohol services, forcing town halls to slash £43m from addiction budgets in one year| Independent, UK

First large scale study of cocaine users leads to breakthrough in drug testing

Scientists from the University of Surrey have developed a rapid and highly sensitive fingerprint test that can take just seconds to confirm whether someone has used cocaine | University of Surrey, UK

EMCDDA–Europol Joint Report on a new psychoactive substance: 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3-carboxamide (CUMYL-4CN-BINACA)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance 1-(4-cyanobutyl)-N-(2-phenylpropan-2-yl)indazole-3- carboxamide, commonly known as CUMYL-4CN-BINACA, through a joint assessment | EMCDDA, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran-2-carboxamide (tetrahydrofuranylfentanyl; THF-F)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-phenyl-N-[1-(2-phenylethyl)piperidin-4-yl]tetrahydrofuran- 2-carboxamide, commonly known as tetrahydrofuranylfentanyl (THF-F), through a joint assessment | EMCDDA, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (ADB-CHMINACA)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3,3-dimethyl-1-oxobutan-2-yl)-1- (cyclohexylmethyl)-1H-indazole-3-carboxamide, commonly known as ADB-CHMINACA, through a joint assessment | EMCDDA, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl)isobutyramide (4-fluoroisobutyrylfentanyl; 4F-iBF)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(4-fluorophenyl)-N-(1-phenethylpiperidin-4-yl) isobutyramide, commonly known as 4-fluoroisobutyrylfentanyl (4F-iBF), through a joint assessment | EMCDDA, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)-1H-indazole-3-carboxamide (AB-CHMINACA)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance N-(1-amino-3-methyl-1-oxobutan-2-yl)-1-(cyclohexylmethyl)- 1H-indazole-3-carboxamide, commonly known as AB-CHMINACA, through a joint assessment | EMCDDA, Portugal

EMCDDA–Europol Joint Report on a new psychoactive substance: methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}-3,3-dimethylbutanoate (5F-MDMB-PINACA; 5F-ADB)

In March 2017, the EMCDDA and Europol examined the available information on the new psychoactive substance methyl 2-{[1-(5-fluoropentyl)-1H-indazole-3-carbonyl]amino}- 3,3-dimethylbutanoate, commonly known as 5F-MDMB-PINACA, through a joint assessment | EMCDDA, Portugal

Psychoactive substances in secure mental health settings

This document reviews the impact of new psychoactive substances (NPS) in secure mental health settings, and makes recommendations for the management of NPS use in these settings | PHE, UK

Dealing with Synthetics: Time to Reframe the Narrative (PDF)

Beginning with an overview of the synthetics market, this Policy Report examines the possible sources of such inertia and critically explores the issues underlying what in many respects represents a key yet largely under discussed feature of the extant international drug control system. It is argued here that, considering its policy history and contemporary dynamics, it is now time to reframe the narrative surrounding the way the international community deals with synthetic drugs | GDPO, UK

'Sober socialites': Rise of health conscious millennials who drink just five units of alcohol a week

A new report has been published which claims that millennials are all “sober socialites,” shunning boozy nights out and pub trips for green smoothies (packed with protein and veg rather than sugary fruit, natch) and wellness festivals | Independent, UK

'The trouble with GHB that you buy in a bottle you can't be guaranteed what it say on the label is in the bottle,' Harry Shapiro, director at DrugWise says. 'For a naive person who drops some in a drink, you have no idea your dosage level.' | The Debrief, UK

Mapping the maze

What support is available for women facing multiple disadvantage across England and Wales? Mapping the Maze aims to identify what and where services exist for women experiencing homelessness, substance misuse, poor mental health, offending and complex needs | Agenda and AVA, UK

Rail bosses to 'look again' at needle exchange closure

ScotRail Alliance is to reconsider the decision to close Scotland's largest needle exchange, located in Glasgow Central Station | BBC, UK

Wrexham drug detox bed wait 'hugely damaging'

People seeking help for drug and alcohol addiction in north Wales are facing a five month wait, Plaid Cymru has said | BBC, UK

Appointment of a Recovery Champion

The Recovery Champion is a new post created as part of the Government’s new Drug Strategy and is an essential part of the Government’s wider programme of work to build a safer, healthier society that protects the most vulnerable in society. The Strategy aims to reduce the number of people taking illicit drugs, and increase the number of people recovering from drug dependence | Cabinet Office, UK

Guidance: Alcohol, drugs and tobacco: commissioning support pack

Annually updated alcohol, drugs and tobacco commissioning support pack for local authorities | PHE, UK

Advisory Council Misuse of Drugs: Performance & Image Enhancing Drugs

Tweets from the Advisory Council on the Misuse of Drugs (ACMD) evidence-gathering day on the use of Performance and Image Enhancing Drugs (PIEDs) | Various, UK

Estimates of the Prevalence of Opiate Use and/or Crack Cocaine Use, 2014/15: Sweep 11 report (PDF)

This report presents the findings of Sweep 11 of the estimates of the prevalence of opiate and/or crack cocaine use (OCU) in England, covering 2014/15. These continue the long time series of OCU prevalence estimates, starting in 2004/05 and most recently reported for 2011/12 | CPH, UK

Campaigners want to end 'normalisation' of groping in clubs, pubs and bars

Campaigners want people to step in and help if they see their friends being sexually harassed in a club or bar | BBC Newsbeat, UK

Highest smoking quit success rates on record

Expert report, which coincides with launch of Stoptober, says there has never been a better time to stop smoking | PHE, UK

Bereavement through Alcohol and Drugs

Bereaved through Alcohol and Drugs (BEAD) is a project that was set up four years ago to offer peer support to people who have lost someone due to drug or alcohol use. Funded by the Big Lottery, it is a result of a partnership between Adfam, a charity which supports the families of drug and alcohol users, and Cruse Bereavement Care, the biggest bereavement organisation in the country | Volteface, UK

Hepatitis C in London: annual review

This report focuses on the epidemiology of hepatitis C in London, mainly using routinely available surveillance data | PHE, UK

Hepatitis C in the South East PHE Centre report

This report focuses on the epidemiology of hepatitis C in the South East area, using, in the main, routinely available surveillance data | PHE, UK